aly688
Peptideexperimental
Clinical trial activity
3 trials · 3 clinical orgs · 0 marketing orgs
Phase 1
2
Phase 2
1
Phase 3
1
Phase 4
0
Earliest trial started Dec 16, 2019 (NCT04201574)
Timeline
Indications
Mechanism of action
- Adiponectin receptor protein 1INHIBITOR
ADIPOR1 inhibitor
Chemistry & pharmacology
- Multi-specific
- No
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT04855565 | Phase 1 | May 19, 2021 | Allysta Pharmaceutical, INC Research, Nucleus Network Ltd |
| NCT04899518 | Phase 2/Phase 3 (Phase 3) | May 19, 2021 | Allysta Pharmaceutical |
| NCT04201574 | Phase 1/Phase 2 (Phase 2) | Dec 16, 2019 | Allysta Pharmaceutical |
Showing 3 of 3 trials
Page 1 / 1
Organizations
Research & Development (3)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Allysta Pharmaceutical | For profit | 3 | 3 | 3 | 2019 |
| INC Research | For profit | 1 | 0 | 1 | 2021 |
| Nucleus Network Ltd | For profit | 1 | 0 | 1 | 2021 |
3 organizations
Page 1 / 1